Literature DB >> 31923997

Treating tumors with minimally invasive therapy: A review.

Ping Wang1, Suhui Sun1, Huide Ma2, Sujuan Sun2, Duo Zhao2, Shumin Wang3, Xiaolong Liang4.   

Abstract

With high level of morbidity and mortality, tumor is one of the deadliest diseases worldwide. Aiming to tackle tumor, researchers have developed a lot of strategies. Among these strategies, the minimally invasive therapy (MIT) is very promising, for its capability of targeting tumor cells and resulting in a small incision or no incisions. In this review, we will first illustrate some mechanisms and characteristics of tumor metastasis from the primary tumor to the secondary tumor foci. Then, we will briefly introduce the history, characteristics, and advantages of some of the MITs. Finally, emphasis will be, respectively, focused on an overview of the state-of-the-art of the HIFU-, PDT-, PTT-and SDT-based anti-tumor strategies on each stage of tumor metastasis.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antitumor strategies; HIFU; MIT; PDT; PTT; Primary tumor; SDT; Secondary tumor; Tumor

Year:  2019        PMID: 31923997     DOI: 10.1016/j.msec.2019.110198

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  3 in total

Review 1.  The Role of Photodynamic Therapy in Triggering Cell Death and Facilitating Antitumor Immunology.

Authors:  Liuchang Tan; Xiaoxiao Shen; Zhiqiang He; Yuangang Lu
Journal:  Front Oncol       Date:  2022-05-27       Impact factor: 5.738

Review 2.  Antitumor Applications of Photothermal Agents and Photothermal Synergistic Therapies.

Authors:  Chaowei Li; Yue Cheng; Dawei Li; Qi An; Wei Zhang; Yu Zhang; Yijun Fu
Journal:  Int J Mol Sci       Date:  2022-07-18       Impact factor: 6.208

3.  Increased PDT Efficacy When Associated with Nitroglycerin: A Study on Retinoblastoma Xenografted on Mice.

Authors:  Carole D Thomas; Mihaela Lupu; Florent Poyer; Philippe Maillard; Joël Mispelter
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.